Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

May 28, 2013

30339_dirs_2013-05-28_568484e2-456e-4133-b817-72f6854dbff3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-05-24

Reporting Person: JOHNSON L ROBERT (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-05-24 Common Stock S 1700.0000 $67.4700 Disposed 21276.9300 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.44 to $67.55, inclusive. The reporting person undertakes to provide to any security holder of West Pharmaceutical Services, Inc. or the staff of the securities and Exchange Commission, upon request, full informatin regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.